53Biologics — Series A (estimated) · €7M

GAEA Inversión and Inveready Biotech III jointly invested €7M, paid in tranches, in Biotechnology Developments for Industry (BDI) to grow its subsidiary 53Biologics into a supplier of enzymes for mRNA production. Inveready Biotech II was already a shareholder. The articles give no stage; Series A is inferred.